Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Verisante Technology Inc. V.VRS


Primary Symbol: V.VER.H

Verisante Technology Inc is a Canada based medical device company. It is engaged in commercializing medical systems for the early detection of cancer. The products of the company are Verisante Aura which is for skin cancer detection and Verisante Core which is for lung, colon and cervical cancer detection. It utilizes a cancer detection platform while the operating software and probe technology. The group generates revenue from the sale and renting of its medical devices.


TSXV:VER.H - Post by User

Bullboard Posts
Post by fjrmotoon Jun 29, 2013 11:15am
249 Views
Post# 21581227

concerned shareholder.......

concerned shareholder.......With less than 1 million raised from our recent pp and a low cash balance as a starting point, the number of sales and the rate at which they are selling is not just important but critical. Promoting the number of sales and their location should be front and centre.... to build and maintain momentum. Our shareprice is down 50%...... we have no analyst coverage......the market has yawned (very low volume) and we are just headed into summer!

What disturbs me is that TB seemed to prefer shareholder dilution to raise op. cash for a two year runway as opposed to sales to self finance this runway. If these world class distributors can't sell the Aura or aren't putting the necessary effort into selling our product, ( for which they will be handsomely rewarded) than stop giving them exclusivity..........and give them performance based targets and make them finance and hold inventory! At this point in time, raising further cash through dilution would be a gross disservice to existing shareholders and financing at reasonable interest rates will be dependant on SALES! 

With regard to my comment regarding the Aura being held back, non performance by exclusive distributors with an agenda paid for by much larger medical device companies could seriously cripple the sales results which we need to survive. Was anyone impressed by Clarions' product launch or website? The sales targets for the infrastructure in place and the size of the market are way too soft......Get a sales and marketing professional to drive this. TB with his chronic sinus congestion doing closeup interviews just doesn't cut it. Time is not on our side....polite soft pumping and avoiding issues on this board has not helped this stock and being set up for a cash crunch with a subsequent takeout at a ridiculously low price seems to be the direction we are going?
Bullboard Posts